Background: Atrial fibrillation is the most common type of cardiac arrhythmia and is associated with elevated rates of stroke, heart failure, hospital admission, and death. Its prevalence in the ...
Introduction: There is insufficient evidence on the efficacy and safety of pharmacological cardioversion of recent-onset atrial fibrillation (AF) in elderly patients. Antazoline has been shown to be ...
However, several factors confound the role of inflammation in generation and perpetuation of AF. As an example, failure to show a correlation between baseline hsCRP levels and maintenance of sinus ...
(HealthDay News) — A delay to cardioversion of ≥12 hours from onset of acute atrial fibrillation symptoms is associated with a greater risk of thromboembolic complications, according to a research ...
DCC was performed in 226 patients and sinus rhythm was restored in 197 individuals without further complications. Ten patients with LAAT were prepared for DCC over the next 4 weeks. Of these, 7 still ...
Direct current cardioversion for symptomatic atrial fibrillation or flutter is feasible and safe in patients implanted with the Watchman left atrial appendage (LAA) occlusion device, even in the ...
Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to new research. Apixaban lowers the ...
MILAN, ITALY — New research has shed light on a mechanism other than multiple infarcts that may contribute to the association between between atrial fibrillation (AF) and decreased brain function [1].
"Due to the risk of thromboembolism, clinical guidelines recommend anticoagulation before and after cardioversion in patients with atrial fibrillation," said Andreas Goette, MD, Chief Physician, St.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback